Suppr超能文献

肠道L细胞机械感受通过胰高血糖素样肽-1调节肝脏脂质代谢。

Intestinal L-cell mechanoreception regulates hepatic lipid metabolism through GLP-1.

作者信息

Gao Luyang, Yang Ke, Zhao Yawen, Zhang Jinshan, Jiang Shaohua, Zhang Rujiao, He Wenxin, Zhao Yuhang, Ye Qianqian, Xu Geyang

机构信息

Department of Physiology, School of Medicine, Jinan University, 601 Huangpu Avenue West, Tianhe District, Guangzhou, Guangdong 510632, China.

Key Laboratory of Viral Pathogenesis & Infection Prevention and Control (Jinan University), Ministry of Education, Guangzhou, Guangdong 510632, China.

出版信息

Sci Adv. 2025 May 30;11(22):eadv3201. doi: 10.1126/sciadv.adv3201.

Abstract

Glucagon-like peptide-1 (GLP-1), secreted by intestinal L cells, is essential for lowering postprandial glucose levels and regulating hepatic lipid metabolism.We investigate the effects of manipulating Piezo1 in L cells on hepatic lipid metabolism. We found that normal and high-fat diet-fed L cell-specific knockout () mice exhibited reduced circulating GLP-1 levels, increased hepatic lipid accumulation, decreased β-catenin expression, and elevated lipogenesis-related genes and proteins, including SREBP1c, PPARγ, FASN, and ACC. Treatment with exendin-4 improved fatty liver in mice by stimulating β-catenin and inhibiting de novo lipogenesis. Intestinal bead implantation stimulated GLP-1 release and inhibited lipid synthesis in livers of diet-induced obese mice but not in mice. In primary hepatocytes derived from mice, lipid accumulation and enhanced fatty acid synthesis were associated with reduced β-catenin expression and impaired nuclear translocation. Exendin-4 treatment alleviated lipid accumulation, which was blocked by the β-catenin inhibitor nitazoxanide. L-cell mechanoreception is vital for regulating hepatic lipid metabolism through GLP-1.

摘要

由肠道L细胞分泌的胰高血糖素样肽-1(GLP-1)对于降低餐后血糖水平和调节肝脏脂质代谢至关重要。我们研究了在L细胞中操控Piezo1对肝脏脂质代谢的影响。我们发现,正常饮食和高脂饮食喂养的L细胞特异性敲除()小鼠循环中的GLP-1水平降低、肝脏脂质积累增加、β-连环蛋白表达减少,以及包括固醇调节元件结合蛋白1c(SREBP1c)、过氧化物酶体增殖物激活受体γ(PPARγ)、脂肪酸合酶(FASN)和乙酰辅酶A羧化酶(ACC)在内的脂肪生成相关基因和蛋白质水平升高。用艾塞那肽-4治疗可通过刺激β-连环蛋白并抑制从头脂肪生成来改善小鼠的脂肪肝。肠道珠植入可刺激饮食诱导肥胖小鼠肝脏中的GLP-1释放并抑制脂质合成,但在小鼠中则不然。在源自小鼠的原代肝细胞中,脂质积累和脂肪酸合成增强与β-连环蛋白表达减少和核转位受损有关。艾塞那肽-4治疗减轻了脂质积累,而β-连环蛋白抑制剂硝唑尼特可阻断这种作用。L细胞机械感受对于通过GLP-1调节肝脏脂质代谢至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c11d/12124353/2f9d922fb49e/sciadv.adv3201-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验